HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · IEX Real-Time Price · USD
0.620
-0.040 (-6.06%)
Jul 19, 2024, 4:00 PM EDT - Market closed
HCW Biologics Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for HCW Biologics.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for HCW Biologics.
Recommendation Trends
| Rating | Jan '23 | Feb '23 | Mar '23 | Apr '23 | May '23 | Jun '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 2 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 2 | 2 | 2 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| EF Hutton | EF Hutton | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +1,351.61% | Jun 1, 2023 |
| EF Hutton | EF Hutton | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +1,351.61% | Apr 19, 2023 |
| EF Hutton | EF Hutton | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +1,351.61% | Mar 30, 2023 |
| EF Hutton | EF Hutton | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +1,351.61% | Mar 23, 2023 |
| JonesTrading | JonesTrading | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +1,190.32% | Nov 8, 2022 |
Financial Forecast
Revenue This Year
1.15M
from 560.36K
Increased by 105.23%
Revenue Next Year
n/a
from 1.15M
EPS This Year
-0.58
from -0.70
EPS Next Year
-0.56
from -0.58
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.2M | n/a | n/a | 56.0M | 168.5M |
| Avg | 1.2M | n/a | n/a | 54.4M | 163.7M |
| Low | 1.1M | n/a | n/a | 52.3M | 157.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 111.1% | - | - | - | 209.6% |
| Avg | 105.2% | - | - | - | 200.8% |
| Low | 97.0% | - | - | - | 189.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.60 | -0.58 | -0.66 |
| Avg | -0.58 | -0.56 | -0.64 |
| Low | -0.56 | -0.54 | -0.62 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.